NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar Depression
Active Not Recruiting
NMDA antagonist drugs have increasingly been demonstrated to reduce symptoms of depression and suicidal ideation. NeuroRx has developed a sequential therapy consisting of IV NRX-100 (ketamine HCL) for rapid stabilization of symptoms of depression and suicidal ideation followed by oral NRX-101 (fixed dose combination of D-cycloserine and lurasidone) for maintenance of stabilization from symptoms of depression and suicidal ideation. This study will test the hypothesis that that NRX-100 is superior... Read More
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
01/17/2024
Locations: JP Smith Hospital, Fort Worth, Texas
Conditions: Bipolar Depression, Suicidal Ideation